ATE326949T1 - Verfahren zur herstellung fester dispersionen - Google Patents

Verfahren zur herstellung fester dispersionen

Info

Publication number
ATE326949T1
ATE326949T1 AT01914278T AT01914278T ATE326949T1 AT E326949 T1 ATE326949 T1 AT E326949T1 AT 01914278 T AT01914278 T AT 01914278T AT 01914278 T AT01914278 T AT 01914278T AT E326949 T1 ATE326949 T1 AT E326949T1
Authority
AT
Austria
Prior art keywords
methods
producing solid
solid dispersions
substances
dispersions
Prior art date
Application number
AT01914278T
Other languages
English (en)
Inventor
Arne Brodin
Sylvan Frank
Chao Ye
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0000934A external-priority patent/SE0000934D0/xx
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Application granted granted Critical
Publication of ATE326949T1 publication Critical patent/ATE326949T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT01914278T 2000-03-09 2001-03-08 Verfahren zur herstellung fester dispersionen ATE326949T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18798400P 2000-03-09 2000-03-09
SE0000934A SE0000934D0 (sv) 2000-03-21 2000-03-21 Method of preparing pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE326949T1 true ATE326949T1 (de) 2006-06-15

Family

ID=26655029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914278T ATE326949T1 (de) 2000-03-09 2001-03-08 Verfahren zur herstellung fester dispersionen

Country Status (11)

Country Link
US (1) US20030104065A1 (de)
EP (1) EP1263413B1 (de)
JP (1) JP2003525895A (de)
AT (1) ATE326949T1 (de)
AU (1) AU2001239625A1 (de)
CY (1) CY1105515T1 (de)
DE (1) DE60119905T2 (de)
DK (1) DK1263413T3 (de)
ES (1) ES2263600T3 (de)
PT (1) PT1263413E (de)
WO (1) WO2001066091A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE10358749A1 (de) 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform zur Bekämpfung von primären Kopfschmerzen
AU2006272438B2 (en) 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
ATE521337T1 (de) * 2007-07-18 2011-09-15 Feyecon Bv Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung
CN102448451A (zh) * 2009-05-29 2012-05-09 森下仁丹株式会社 口腔用药剂组合物及封入了其的口腔用药剂胶囊
ES2542012T3 (es) * 2011-03-07 2015-07-29 3M Innovative Properties Company Dispositivos de microagujas y métodos
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CN108096195B (zh) * 2018-01-08 2020-01-24 中国药科大学 超临界抗溶剂法制备阿齐沙坦固体分散体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169433A (en) * 1990-07-18 1992-12-08 Formulogics, Inc. Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
SI9400079B (sl) * 1994-02-15 2003-02-28 Dr. Weidner Eckhard, Dipl. Ing. Postopek in naprava za pridobivanje in frakcioniranje majhnih delcev iz raztopin nasičenih s plinom
CN1233169A (zh) * 1996-10-14 1999-10-27 弗·哈夫曼-拉罗切有限公司 一种粉末状制剂的制备工艺
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
KR20010042566A (ko) * 1998-04-09 2001-05-25 프리돌린 클라우스너, 롤란드 비. 보레르 압축된 기체 및 계면활성제중에 용해시킴으로써, 크기가마이크론 이하인 입자를 제조하는 방법
CA2335472C (en) * 1998-06-19 2008-10-28 Rtp Pharma Inc. Processes to generate submicron particles of water-insoluble compounds
US20020041898A1 (en) * 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents

Also Published As

Publication number Publication date
EP1263413A1 (de) 2002-12-11
WO2001066091A1 (en) 2001-09-13
CY1105515T1 (el) 2010-07-28
JP2003525895A (ja) 2003-09-02
PT1263413E (pt) 2006-08-31
DK1263413T3 (da) 2006-09-11
DE60119905T2 (de) 2007-01-11
AU2001239625A1 (en) 2001-09-17
US20030104065A1 (en) 2003-06-05
ES2263600T3 (es) 2006-12-16
EP1263413B1 (de) 2006-05-24
DE60119905D1 (de) 2006-06-29

Similar Documents

Publication Publication Date Title
EA200900270A1 (ru) Системы регулируемого высвобождения и способ их приготовления
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
WO2007128923A3 (fr) Procede de preparation d'un gel biocompatible a libération contrôlée d'un ou de plusieurs principes actifs peu solubles dans l'eau, gels ainsi obtenus et leur utilisation
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
ATE326949T1 (de) Verfahren zur herstellung fester dispersionen
BR0011772A (pt) Conjugado de droga-oligÈmero, composição farmacêutica, método de solubilização de uma droga em uma microemulsão, e, métodos para fornecer um conjugado de droga ativa - hidrófilo e um conjugado de droga ativa - peg a um sìtio de um indivìduo
AR033168A1 (es) Solucion oral de aripiprazol
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
ATE432063T1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
DE60323953D1 (de) Verfahren zur herstellung einer fein selbstemulgierbaren pharmazeutischen zusammensetzung
CA2372339A1 (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
AR082579A2 (es) Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
ATE415410T1 (de) Pharmazeutische zusammensetzung zur behandlung von psoriasis und anderen hautkrankheiten
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
WO2007054976A3 (en) Lipid based controlled release pharmaceutical composition
CA2356959A1 (en) Water-insoluble drug delivery system
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
WO2006007354A3 (en) A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
FR2854159B1 (fr) Nouveaux derives de l'indole, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de kdr
ATE220914T1 (de) Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung
ATE355069T1 (de) Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen
EP1663154A4 (de) I mahonia /i i aquifolium /i extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263413

Country of ref document: EP

REN Ceased due to non-payment of the annual fee